Skip to main content
Glama

Data Va

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already provide readOnly, idempotent, and openWorld hints, and the description adds significant behavioral context: graceful degradation when GLEIF/OpenFIGI is unavailable, explicit `unresolved` output, source-labelled identifiers, `figi_candidates` on ambiguity, and internal multi-endpoint cascading. This goes well beyond the structured annotations and gives the agent a reliable model of tool behavior.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but dense, and most sentences earn their place by providing trigger examples, supported types, resolution behavior, and caveats. It is front-loaded with the core purpose and the 'Use FIRST' directive. Slight verbosity around the `figi_candidates` explanation prevents a perfect conciseness score.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries return-value burden and does disclose key output concepts: `figi_candidates`, `unresolved`, source labels, and enrichment fallback. It covers input forms, entity types, and edge cases. It could be even more complete by describing the overall response container or error behavior, but it is strong enough for selection and invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description adds substantial value beyond the schema. It gives concrete examples for `value`, clarifies that ticker/CIK/ISIN/name forms are accepted, and warns about the bond issuer-name-only trap with an illustrative counterexample. This is exactly the kind of semantic enrichment that prevents incorrect invocations.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description uses a specific action verb and resource: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It also provides concrete trigger phrases and explicitly separates 'company' and 'drug' entity types. This makes the tool's purpose unmistakable and distinct from sibling tools like entity_profile or compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit guidance: 'Use FIRST whenever you have a name but need an ID.' It also explains when the tool is the right choice, including for non-equity instruments and drug lookups. It does not explicitly name alternatives or give when-not-to-use conditions, so it stops short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Data Va toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

Several tool clusters are near-duplicates or easy to confuse: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are nearly identical (beta currently matches stable exactly), while polymarket_edges, polymarket_arbitrage, and bet_research all scan prediction-market opportunities with overlapping outputs. entity_profile/compare_entities/recent_changes and ai_visibility_check/scan_competitor_ai_presence add further redundancy. Despite detailed descriptions, the boundaries require careful reading, so an agent is likely to misselect.

Naming Consistency3/5

All names are snake_case and readable, with useful prefixes like ask_, polymarket_, pipeworx_, and scan_. However, conventions are mixed: verb_noun (ask_pipeworx, list_subscriptions, resolve_entity) coexists with bare nouns (datasets, metadata, query) and noun-first compounds (entity_profile, bet_research, deep_research). There is no single predictable pattern.

Tool Count2/5

34 tools is above the 25-tool threshold, and the set spans multiple unrelated domains such as data routing, prediction markets, memory, subscriptions, Virginia Open Data, AI visibility, and npm dependency checks. Several tools are effectively wrappers or near-overlaps that could be consolidated, e.g., ai_visibility_check vs scan_competitor_ai_presence and polymarket_edges vs polymarket_arbitrage. The surface feels bloated for a single server.

Completeness4/5

Within its main sub-domains the set is solid: memory has remember/recall/forget, subscriptions have subscribe/unsubscribe/list/recent_alerts, research has resolve_entity/compare_entities/entity_profile/recent_changes/validate_claim, and Polymarket has detection/arbitrage/fill-risk/edge-tracking. Minor gaps exist — no tool to fetch a raw pipeworx:// record, no write/update for Virginia Open Data, and no trade execution for prediction markets — but these do not create dead ends for a research-focused agent.

Resources